AID manufactures and distributes diagnostic products and imaging devices.

Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden.

OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Jiangsu Dingtai Pharmaceutical Research Co., Ltd., established on 2008-06-10, Business scope includes drugs,natural product,cosmetic,Research and development of safety evaluation of functional food and health-related products,Technical Services,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Dakwin Bioengineering Co., Ltd., established on 2011-12-15, Business scope includes general business items:R&D and sales of experimental reagents and instruments;Lymphocyte Separation Medium,Compounding and aliquoting of serum-free medium;Biotechnology information consulting and technical services;Import and export of goods or technology;Domestic Trade(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software sales;Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Production of Class I Medical Devices;Production of Class II Medical Devices;Sales of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Part of Spirent Communications Plc, Adtech, Inc. is a company headquartered in Honolulu, HI, that makes test equipment for high speed digital telecommunication companies. Tim Shadburn is currently the CEO of the firm. On May 19, 1997 Spirent Communications Plc acquired Adtech, Inc. for $76.30 million.

Wuhan Dangkangxingzhong Biotechnology Co., Ltd., established on 2020-11-26, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Veterinary drug production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Development of Human Gene Diagnosis and Therapy Technology;R&D of industrial enzyme preparations;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Veterinary special instruments and machinery manufacturing;Veterinary special equipment sales;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shenzhen Zhonghengxiang Biological Immunotechnology Co., Ltd., established on 2021-01-29, Business scope includes general business items:Sales of Class I Medical Devices;Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Health Consulting Services(Does not include medical services).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Class III medical device business;Inspection and testing service;Sales of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenzhen Xinhe Ruien Biomedical Technology Co., Ltd., established on 2020-11-17, Business scope includes general business items:Biotechnology,information Technology,Medical Technology,software technology development,technical consulting,Transfer of self-owned technological achievements(The above does not include medical behavior);Health and wellness management consulting(Does not contain medical behavior);Technology Development in Biomedical Engineering;electronic product,Sales of daily necessities;Operating import and export business.(Laws of the above items,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council,Restricted projects must obtain a license before operating),The licensing program is:sales of biological products.

Guangzhou Ruihui Biotechnology Co., Ltd., established on 2012-08-07, Business scope includes medical research and experimental development;New material technology research and development;Production of Class I Medical Devices;daily mask(non-medical)Production;Production of special labor protection products;Sales of hygiene products and single-use medical products;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Non-residential real estate leases;property management;New material technology promotion service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Disinfectant sales(Free of Hazardous Chemicals);Domestic trade agent;internet sales(Except for products that require a license for sale);Park Management Services;Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;Certification Consulting;Business Management Consulting;Intellectual Property Services;Technology intermediary service;Entrepreneurial Space Services;marketing planning;Socioeconomic Advisory Services;Property Service Evaluation;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of hygiene products and single-use medical products;Production of protective equipment for medical personnel(Class II medical device);Disinfectant production(Free of Hazardous Chemicals);Import and export;Class III medical device business;Production of medical masks

Guangzhou Diao Medical Technology Co., Ltd., established on 2014-07-21, Business scope includes biotechnology consulting,communication service;Operation of non-licensed medical devices;Import and export(Excluding franchised products);Biotechnology Transfer Services;Biotechnology Development Services;car retail;Retailing of office equipment consumables;Wholesale of office equipment consumables;software service;software retail;Instrument wholesale;Instrument Repair;Sales of Biological Products(Does not include licensed operations);Sales of biological diagnostic reagents and kits(Does not include license approval items);Manufacturing of experimental analysis instruments;Commodity wholesale trade(Except for licensed and approved products);Technology Import and Export;Commodity retail trade(Except for licensed and approved products);Manufacturing of instrumentation and other general instruments for supply;Manufacturing of electronic measuring instruments;Optical Instrument Manufacturing;Components for general and special purpose instrumentation,Device manufacturing;Medical supplies and equipment retail(Does not contain drugs and medical devices);Auto Parts Retail;motorcycle retail;computer retail;Electronics retail;General machinery and equipment retail;Machinery Parts Retail;Chemical Product Retail(Excluding hazardous chemicals);Food Science and Technology Research Services;medical diagnosis,Monitoring and treatment equipment manufacturing;Licensed medical device business;

NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA.

NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.